Skip to content

Clinical trials

Phase 2 Uterine Cervical Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20141
20151
20171
20181
20201
20213
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AstraZeneca1
Bayer1
Belgian Gynaecological Oncology Group1
Catholic University of the Sacred Heart1
Daiichi Sankyo1
GlaxoSmithKline1
Iovance Biotherapeutics, Inc.1
Merck Sharp & Dohme LLC1
National Cancer Institute, Naples1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms14
Breast Neoplasms3
Endometrial Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.